SEMINAR
Health Technology Assessment (HTA) and Clinical Engineering: Emerging Challenges for BME Education and Profession.
Time: 6.00pm. Light refreshments will be served at 5:30pm. Venue: National University of Singapore. 4 Engineering Drive 3, Singapore 117583 (map). Room E4-04-02.
Abstract
“Biomedical Engineering is not simply a subset of modern medicine. Modern medicine predominantly secures important advances through the use of the products of biomedical engineering”. This is the initial statement of a recent report published by the European Economic and Social Committee on the Official Journal of the European Union (C291/45), highlighting the importance of BME social and economic impact. HTA and Clinical Engineering represent two front ends of BME. The former because is the tool used by modern democracies to inform decisions regarding the adoption of new healthcare technologies at National, Regional and Hospital Level. The latter because it is one of the main employment for BMEs in Hospital, and most likely the first seen by our medical doctor fellows and patients.
This talk will be a reflection on the main challenges that BME will have to face in the next years in those two important fields, how this is impacting on BME education and profession, and what the IFMBE is doing to help BMEs worldwide to face those challenges.
Biodata
Leandro Pecchia received the degree in Biomedical Engineering in 2005 and the PhD in Economy and Management of Healthcare Services and Organizations in 2009 from the University “Federico II” of Naples, under the supervision of Prof Marcello Bracale. He is now Assistant Professor of Biomedical Engineering at The University of Warwick, Coventry, UK, where he directs the Applied Biomedical Signal Processing and Intelligent eHealth Lab (ABSPIE). He has authored or co-authored about 90 journal, book and conference papers in the fields of machine learning and biomedical signal processing applied to healthy ageing, chronic diseases and falls in the elderly. Dr Pecchia is the Chairman of the Health Technology Assessment Division of the International Federation of Medical and Biomedical Engineering (IFMBE) and Chair of the Public Affair Working Group of the European Alliance of Medical and Biological Engineering and Science.